Noevir Holdings Co., Ltd.
Results for the First Half of Fiscal 2025
（ October 1, 2024 - March 31, 2025 ）
May 15, 2025
Noevir Holdings Co., Ltd.
Ikkou Yoshida, Managing Director
Copyright © 2025 Noevir Holdings Co., Ltd. All Rights Reserved.
Company Overview
Noevir Holdings Co., Ltd. Tokyo Stock Exchange, Prime Market Ticker: 4928
Date of Establishment March 22, 2011 (Noevir Co., Ltd. was founded in April 1964.) Paid-in Capital ¥7,319 million
Consolidated Subsidiaries 13 subsidiaries (6 domestic / 7 international)
Employees 1,369 (Consolidated) (As of September 30, 2024)
Number of Shareholders 22,943 (As of March 31, 2025) Outstanding Shares 34,156 thousand shares
Cosmetics
Market Capitalization ¥145.507 billion (As of May 14, 2025 @ ¥4,260) Line of Business
Pharmaceuticals & Health Food
Other
Apparel business Aviation-related business
Results for the First Half of Fiscal 2025
The First Half of Fiscal 2025 Segment-Based Highlights
Medium- to Long-term Strategy
Forecasts and Initiatives
for the Second Half of Fiscal 2025
Results for the First Half of Fiscal 2025
1
Consolidated Results Summary
Increased sales, decreased operating income,
and increased net income vs. actual results year on year
Net sales | 32.0 billion yen | 1.3％ |
Operating income | 5.7 billion yen | (7.3％) |
1st half of fiscal 2025 | Year-on-year change |
Net income attributable to owners of the parent
2.6 billion yen 1.7％
Operating income margin 17.8％ (1.7pt)
Operating income margin
17.8％
Factors increasing sales and decreasing profits
（Factors increasing net income）
①Functional drinks performed strongly
Face-to-face channel cosmetics performed firmly
②Product mix changes
③Increased marketing costs
④Recording of extraordinary income
Results for the First Half of Fiscal 2025
1
Income Statement
Net sales 32.0 billion yen (+1.3% year-on-year), operating income 5.7 billion yen (-7.3%),
ordinary income 6.0 billion yen (-3.5%), net income attributable to owners of the parent 2.6 billion yen (+1.7%)
1st half ended March 31, 2025 | 1st half ended March 31, 2024 | Year-on-year change | |||
Millions of yen | Millions of yen | Millions of yen | ％ | ||
Net sales | 32,037 | 31,625 | 411 | 1.3 | |
Cost of sales | 10,414 | 9,935 | 478 | 4.8 | |
Gross profit | 21,622 | 21,689 | (67) | (0.3) | |
SG&A | 15,910 | 15,524 | 386 | 2.5 | |
Operating income | 5,712 | 6,165 | (453) | (7.3) | |
Non-operating income (expenses) | 313 | 80 | 232 | 286.9 | |
Ordinary income | 6,025 | 6,246 | (221) | (3.5) | |
Extraordinary income (loss) | 87 | 13 | 74 | 539.2 | |
Income before income taxes | 6,112 | 6,259 | (146) | (2.3) | |
Income taxes | 3,471 | 3,661 | (190) | (5.2) | |
Net income attributable to owners of the parent | 2,641 | 2,597 | 43 | 1.7 | |
Cost of sales ratio (%) | 32.5 | 31.4 | ー | 1.1pt | |
Operating income margin (%) | 17.8 | 19.5 | ー | (1.7pt) | |
Ordinary income margin (%) | 18.8 | 19.8 | ー | (0.9pt) | |
Net income attributable to owners of the parent margin (%) | 8.2 | 8.2 | ー | 0.0pt | |
SG&A ratio (%) | 49.7 | 49.1 | ー | 0.6pt | |